You just read:

AbbVie Presents Pivotal Phase 3 Data on Investigational Treatment Elagolix and Research on the Economic Burden of Endometriosis at the 72nd American Society for Reproductive Medicine Scientific Congress

News provided by

AbbVie

06 Oct, 2016, 08:00 ET